BWM
BMY icon

Birchcreek Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Birchcreek Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,825
Closed -$233K – 116
2025
Q1 		$233K Hold
3,825
– – 0.15% 100
2024
Q4 		$216K Buy
+3,825
New +$214K 0.14% 110
2024
Q2 		– Sell
-3,872
Closed -$210K – 155
2024
Q1 		$210K Buy
+3,872
New +$197K 0.11% 150
2021
Q1 		– Sell
-1,000
Closed -$62K – 134
2020
Q4 		$62K Buy
+1,000
New +$61.5K 0.06% 191

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Birchcreek Wealth Management's BMY Position: Q2 2025 in Review

Birchcreek Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,825 shares — an estimated $233K sold.

Birchcreek Wealth Management first reported a position in BMY in Q4 2020 and held it in 4 quarters. The position peaked at $233K in Q1 2025. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Birchcreek Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Birchcreek Wealth Management sold 3,825 Bristol-Myers Squibb shares in Q2 2025, an estimated $233K.
  • Birchcreek Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 4 quarters.
  • Birchcreek Wealth Management's Bristol-Myers Squibb position peaked at $233K in Q1 2025.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Birchcreek Wealth Management's 13F filing for Q2 2025, filed 7 Aug 2025.